Treatment Site: 0 Cranial Cavity; K Upper Back; L Lower Back; P Gastrointestinal Tract; Q Respiratory Tract; R Genitourinary Tract; X Upper Extremity; Y Lower Extremity
Modality Qualifier: B Low Dose Rate (LDR)
Isotope: B Palladium 103 (Pd-103)
Qualifier: 1 Unidirectional Source; Z None
Row 2
Treatment Site: 1 Head and Neck; 2 Chest; 3 Abdomen; 6 Pelvic Region
Modality Qualifier: 9 High Dose Rate (HDR)
Isotope: 7 Cesium 137 (Cs-137); 8 Iridium 192 (Ir-192); 9 Iodine 125 (I-125); B Palladium 103 (Pd-103); C Californium 252 (Cf-252); Y Other Isotope
Qualifier: Z None
Row 3
Treatment Site: 1 Head and Neck; 2 Chest; 3 Abdomen; 6 Pelvic Region
Modality Qualifier: B Low Dose Rate (LDR)
Isotope: 6 Cesium 131 (Cs-131); 7 Cesium 137 (Cs-137); 8 Iridium 192 (Ir-192); 9 Iodine 125 (I-125); C Californium 252 (Cf-252); Y Other Isotope
Qualifier: Z None
Row 4
Treatment Site: 1 Head and Neck; 2 Chest; 3 Abdomen; 6 Pelvic Region